nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0849	0.215	CbGbCtD
Fentanyl—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0574	0.145	CbGbCtD
Fentanyl—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0547	0.139	CbGbCtD
Fentanyl—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0488	0.124	CbGbCtD
Fentanyl—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0478	0.121	CbGbCtD
Fentanyl—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0451	0.114	CbGbCtD
Fentanyl—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0286	0.0726	CbGbCtD
Fentanyl—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.027	0.0685	CbGbCtD
Fentanyl—Trimethaphan—CHRNA3—chronic obstructive pulmonary disease	0.00389	0.391	CrCbGaD
Fentanyl—Quinapril—ACE—chronic obstructive pulmonary disease	0.00151	0.152	CrCbGaD
Fentanyl—Benazepril—ACE—chronic obstructive pulmonary disease	0.00131	0.132	CrCbGaD
Fentanyl—Alfentanil—ALB—chronic obstructive pulmonary disease	0.000817	0.0821	CrCbGaD
Fentanyl—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000632	0.0635	CrCbGaD
Fentanyl—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000531	0.0533	CrCbGaD
Fentanyl—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.00053	0.0532	CrCbGaD
Fentanyl—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000368	0.037	CrCbGaD
Fentanyl—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000355	0.0357	CrCbGaD
Fentanyl—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.000635	CcSEcCtD
Fentanyl—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000346	0.000634	CcSEcCtD
Fentanyl—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000345	0.000633	CcSEcCtD
Fentanyl—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.000632	CcSEcCtD
Fentanyl—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000631	CcSEcCtD
Fentanyl—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000342	0.000628	CcSEcCtD
Fentanyl—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000341	0.000625	CcSEcCtD
Fentanyl—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.000623	CcSEcCtD
Fentanyl—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.000623	CcSEcCtD
Fentanyl—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000619	CcSEcCtD
Fentanyl—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000336	0.000616	CcSEcCtD
Fentanyl—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.000616	CcSEcCtD
Fentanyl—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000335	0.000613	CcSEcCtD
Fentanyl—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.000613	CcSEcCtD
Fentanyl—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.000612	CcSEcCtD
Fentanyl—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.000611	CcSEcCtD
Fentanyl—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000333	0.00061	CcSEcCtD
Fentanyl—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.000608	CcSEcCtD
Fentanyl—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.000605	CcSEcCtD
Fentanyl—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.000602	CcSEcCtD
Fentanyl—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.000602	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000328	0.000601	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.000601	CcSEcCtD
Fentanyl—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.000597	CcSEcCtD
Fentanyl—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000326	0.000597	CcSEcCtD
Fentanyl—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.000594	CcSEcCtD
Fentanyl—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000324	0.000593	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000321	0.000589	CcSEcCtD
Fentanyl—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.000588	CcSEcCtD
Fentanyl—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000321	0.000588	CcSEcCtD
Fentanyl—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.000586	CcSEcCtD
Fentanyl—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00032	0.000586	CcSEcCtD
Fentanyl—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000319	0.000584	CcSEcCtD
Fentanyl—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000582	CcSEcCtD
Fentanyl—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000317	0.000581	CcSEcCtD
Fentanyl—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.000581	CcSEcCtD
Fentanyl—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00058	CcSEcCtD
Fentanyl—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000316	0.000578	CcSEcCtD
Fentanyl—Injury—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000575	CcSEcCtD
Fentanyl—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000313	0.000574	CcSEcCtD
Fentanyl—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.000573	CcSEcCtD
Fentanyl—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.000572	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000569	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000569	CcSEcCtD
Fentanyl—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00031	0.000569	CcSEcCtD
Fentanyl—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00031	0.000569	CcSEcCtD
Fentanyl—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.000569	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.000567	CcSEcCtD
Fentanyl—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.000564	CcSEcCtD
Fentanyl—Pain—Formoterol—chronic obstructive pulmonary disease	0.000308	0.000564	CcSEcCtD
Fentanyl—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000308	0.000564	CcSEcCtD
Fentanyl—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.000564	CcSEcCtD
Fentanyl—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.000563	CcSEcCtD
Fentanyl—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000562	CcSEcCtD
Fentanyl—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000562	CcSEcCtD
Fentanyl—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.000559	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000304	0.000558	CcSEcCtD
Fentanyl—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000304	0.000557	CcSEcCtD
Fentanyl—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000555	CcSEcCtD
Fentanyl—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000554	CcSEcCtD
Fentanyl—Pain—Montelukast—chronic obstructive pulmonary disease	0.000301	0.000553	CcSEcCtD
Fentanyl—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000301	0.000551	CcSEcCtD
Fentanyl—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000549	CcSEcCtD
Fentanyl—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.000548	CcSEcCtD
Fentanyl—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.000546	CcSEcCtD
Fentanyl—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.000546	CcSEcCtD
Fentanyl—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.000544	CcSEcCtD
Fentanyl—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000544	CcSEcCtD
Fentanyl—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000544	CcSEcCtD
Fentanyl—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.000543	CcSEcCtD
Fentanyl—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000541	CcSEcCtD
Fentanyl—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00054	CcSEcCtD
Fentanyl—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000539	CcSEcCtD
Fentanyl—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000539	CcSEcCtD
Fentanyl—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000539	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.000538	CcSEcCtD
Fentanyl—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.000537	CcSEcCtD
Fentanyl—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000533	CcSEcCtD
Fentanyl—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000533	CcSEcCtD
Fentanyl—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000528	CcSEcCtD
Fentanyl—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000528	CcSEcCtD
Fentanyl—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000528	CcSEcCtD
Fentanyl—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000524	CcSEcCtD
Fentanyl—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000524	CcSEcCtD
Fentanyl—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000285	0.000521	CcSEcCtD
Fentanyl—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.000521	CcSEcCtD
Fentanyl—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000285	0.000521	CcSEcCtD
Fentanyl—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.000521	CcSEcCtD
Fentanyl—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00052	CcSEcCtD
Fentanyl—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000284	0.00052	CcSEcCtD
Fentanyl—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000516	CcSEcCtD
Fentanyl—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.000515	CcSEcCtD
Fentanyl—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.000515	CcSEcCtD
Fentanyl—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.000515	CcSEcCtD
Fentanyl—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00028	0.000513	CcSEcCtD
Fentanyl—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000513	CcSEcCtD
Fentanyl—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.000512	CcSEcCtD
Fentanyl—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.000512	CcSEcCtD
Fentanyl—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000279	0.000511	CcSEcCtD
Fentanyl—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000279	0.000511	CcSEcCtD
Fentanyl—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00051	CcSEcCtD
Fentanyl—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000509	CcSEcCtD
Fentanyl—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.000505	CcSEcCtD
Fentanyl—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000504	CcSEcCtD
Fentanyl—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.000503	CcSEcCtD
Fentanyl—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000502	CcSEcCtD
Fentanyl—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000273	0.0005	CcSEcCtD
Fentanyl—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000495	CcSEcCtD
Fentanyl—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000492	CcSEcCtD
Fentanyl—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000492	CcSEcCtD
Fentanyl—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000265	0.000486	CcSEcCtD
Fentanyl—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.000486	CcSEcCtD
Fentanyl—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.000485	CcSEcCtD
Fentanyl—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.000485	CcSEcCtD
Fentanyl—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000481	CcSEcCtD
Fentanyl—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00026	0.000476	CcSEcCtD
Fentanyl—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000258	0.000473	CcSEcCtD
Fentanyl—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.000473	CcSEcCtD
Fentanyl—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000255	0.000467	CcSEcCtD
Fentanyl—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.000467	CcSEcCtD
Fentanyl—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000466	CcSEcCtD
Fentanyl—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000253	0.000464	CcSEcCtD
Fentanyl—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00046	CcSEcCtD
Fentanyl—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000459	CcSEcCtD
Fentanyl—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000249	0.000457	CcSEcCtD
Fentanyl—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.000451	CcSEcCtD
Fentanyl—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000246	0.000451	CcSEcCtD
Fentanyl—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.000449	CcSEcCtD
Fentanyl—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.000447	CcSEcCtD
Fentanyl—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000445	CcSEcCtD
Fentanyl—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000241	0.000442	CcSEcCtD
Fentanyl—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.000441	CcSEcCtD
Fentanyl—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.000438	CcSEcCtD
Fentanyl—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000238	0.000436	CcSEcCtD
Fentanyl—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.000436	CcSEcCtD
Fentanyl—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000233	0.000427	CcSEcCtD
Fentanyl—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000427	CcSEcCtD
Fentanyl—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000426	CcSEcCtD
Fentanyl—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00042	CcSEcCtD
Fentanyl—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.000419	CcSEcCtD
Fentanyl—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000229	0.000419	CcSEcCtD
Fentanyl—Rash—Formoterol—chronic obstructive pulmonary disease	0.000227	0.000416	CcSEcCtD
Fentanyl—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.000416	CcSEcCtD
Fentanyl—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.000416	CcSEcCtD
Fentanyl—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000227	0.000416	CcSEcCtD
Fentanyl—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000415	CcSEcCtD
Fentanyl—Headache—Formoterol—chronic obstructive pulmonary disease	0.000225	0.000413	CcSEcCtD
Fentanyl—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.000413	CcSEcCtD
Fentanyl—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000413	CcSEcCtD
Fentanyl—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000413	CcSEcCtD
Fentanyl—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.000412	CcSEcCtD
Fentanyl—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000412	CcSEcCtD
Fentanyl—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000224	0.000411	CcSEcCtD
Fentanyl—Rash—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000407	CcSEcCtD
Fentanyl—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000407	CcSEcCtD
Fentanyl—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000406	CcSEcCtD
Fentanyl—Depression—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000406	CcSEcCtD
Fentanyl—Headache—Montelukast—chronic obstructive pulmonary disease	0.000221	0.000405	CcSEcCtD
Fentanyl—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000399	CcSEcCtD
Fentanyl—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.000396	CcSEcCtD
Fentanyl—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000395	CcSEcCtD
Fentanyl—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000393	CcSEcCtD
Fentanyl—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000393	CcSEcCtD
Fentanyl—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000393	CcSEcCtD
Fentanyl—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000392	CcSEcCtD
Fentanyl—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.000392	CcSEcCtD
Fentanyl—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000214	0.000392	CcSEcCtD
Fentanyl—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00039	CcSEcCtD
Fentanyl—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.000385	CcSEcCtD
Fentanyl—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000209	0.000384	CcSEcCtD
Fentanyl—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000379	CcSEcCtD
Fentanyl—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000378	CcSEcCtD
Fentanyl—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000372	CcSEcCtD
Fentanyl—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00037	CcSEcCtD
Fentanyl—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000368	CcSEcCtD
Fentanyl—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000367	CcSEcCtD
Fentanyl—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000365	CcSEcCtD
Fentanyl—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000364	CcSEcCtD
Fentanyl—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000359	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000357	CcSEcCtD
Fentanyl—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000357	CcSEcCtD
Fentanyl—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000351	CcSEcCtD
Fentanyl—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000349	CcSEcCtD
Fentanyl—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000345	CcSEcCtD
Fentanyl—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000341	CcSEcCtD
Fentanyl—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000339	CcSEcCtD
Fentanyl—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000332	CcSEcCtD
Fentanyl—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00033	CcSEcCtD
Fentanyl—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000326	CcSEcCtD
Fentanyl—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000323	CcSEcCtD
Fentanyl—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000323	CcSEcCtD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000175	0.00349	CbGpPWpGaD
Fentanyl—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000321	CcSEcCtD
Fentanyl—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00032	CcSEcCtD
Fentanyl—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000175	0.00348	CbGpPWpGaD
Fentanyl—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000318	CcSEcCtD
Fentanyl—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000318	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000171	0.00341	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00017	0.00339	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00017	0.00338	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000169	0.00338	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000169	0.00337	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000167	0.00333	CbGpPWpGaD
Fentanyl—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000305	CcSEcCtD
Fentanyl—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000164	0.0003	CcSEcCtD
Fentanyl—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000162	0.00323	CbGpPWpGaD
Fentanyl—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000295	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000294	CcSEcCtD
Fentanyl—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000294	CcSEcCtD
Fentanyl—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000292	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000159	0.00318	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00316	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000158	0.00315	CbGpPWpGaD
Fentanyl—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000287	CcSEcCtD
Fentanyl—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00312	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000156	0.00312	CbGpPWpGaD
Fentanyl—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000286	CcSEcCtD
Fentanyl—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000285	CcSEcCtD
Fentanyl—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000156	0.0031	CbGpPWpGaD
Fentanyl—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000284	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000154	0.00307	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000153	0.00306	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000153	0.00305	CbGpPWpGaD
Fentanyl—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00028	CcSEcCtD
Fentanyl—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000151	0.00301	CbGpPWpGaD
Fentanyl—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000276	CcSEcCtD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.00015	0.003	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00015	0.00299	CbGpPWpGaD
Fentanyl—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000275	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000149	0.00298	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000148	0.00295	CbGpPWpGaD
Fentanyl—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000271	CcSEcCtD
Fentanyl—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000271	CcSEcCtD
Fentanyl—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00294	CbGpPWpGaD
Fentanyl—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00027	CcSEcCtD
Fentanyl—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00293	CbGpPWpGaD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000269	CcSEcCtD
Fentanyl—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000268	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000146	0.00291	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.0029	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00289	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000263	CcSEcCtD
Fentanyl—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00284	CbGpPWpGaD
Fentanyl—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00026	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00026	CcSEcCtD
Fentanyl—Infection—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000258	CcSEcCtD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00014	0.00279	CbGpPWpGaD
Fentanyl—Shock—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000255	CcSEcCtD
Fentanyl—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000255	CcSEcCtD
Fentanyl—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000253	CcSEcCtD
Fentanyl—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000252	CcSEcCtD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000137	0.00273	CbGpPWpGaD
Fentanyl—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000251	CcSEcCtD
Fentanyl—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000247	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000134	0.00268	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000134	0.00267	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000132	0.00264	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00013	0.0026	CbGpPWpGaD
Fentanyl—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000237	CcSEcCtD
Fentanyl—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000236	CcSEcCtD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00256	CbGpPWpGaD
Fentanyl—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000235	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000128	0.00255	CbGpPWpGaD
Fentanyl—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000233	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000127	0.00253	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000126	0.00252	CbGpPWpGaD
Fentanyl—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000229	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000124	0.00247	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000123	0.00246	CbGpPWpGaD
Fentanyl—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000226	CcSEcCtD
Fentanyl—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000225	CcSEcCtD
Fentanyl—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000225	CcSEcCtD
Fentanyl—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000122	0.00244	CbGpPWpGaD
Fentanyl—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000224	CcSEcCtD
Fentanyl—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000224	CcSEcCtD
Fentanyl—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000222	CcSEcCtD
Fentanyl—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000121	0.00241	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000119	0.00237	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000118	0.00235	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000117	0.00234	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000117	0.00234	CbGpPWpGaD
Fentanyl—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000214	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000117	0.00232	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000116	0.00231	CbGpPWpGaD
Fentanyl—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000212	CcSEcCtD
Fentanyl—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000212	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000116	0.00231	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.0023	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000114	0.00228	CbGpPWpGaD
Fentanyl—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00227	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000113	0.00226	CbGpPWpGaD
Fentanyl—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000206	CcSEcCtD
Fentanyl—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000112	0.00224	CbGpPWpGaD
Fentanyl—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000205	CcSEcCtD
Fentanyl—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000205	CcSEcCtD
Fentanyl—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000111	0.00221	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000108	0.00216	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000108	0.00215	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000107	0.00213	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00213	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.0021	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000191	CcSEcCtD
Fentanyl—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000104	0.00207	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000103	0.00206	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000103	0.00205	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000102	0.00204	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00203	CbGpPWpGaD
Fentanyl—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000186	CcSEcCtD
Fentanyl—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000184	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.92e-05	0.00198	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.81e-05	0.00196	CbGpPWpGaD
Fentanyl—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000178	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.66e-05	0.00193	CbGpPWpGaD
Fentanyl—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000172	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.35e-05	0.00186	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.33e-05	0.00186	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	9.33e-05	0.00186	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	9.14e-05	0.00182	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.12e-05	0.00182	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.04e-05	0.0018	CbGpPWpGaD
Fentanyl—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.01e-05	0.000165	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.94e-05	0.00178	CbGpPWpGaD
Fentanyl—Rash—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.000164	CcSEcCtD
Fentanyl—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000164	CcSEcCtD
Fentanyl—Headache—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.000163	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.7e-05	0.00174	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	8.65e-05	0.00172	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.63e-05	0.00172	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	8.58e-05	0.00171	CbGpPWpGaD
Fentanyl—Nausea—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000154	CcSEcCtD
Fentanyl—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.3e-05	0.00165	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.27e-05	0.00165	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.21e-05	0.00164	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.12e-05	0.00162	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.11e-05	0.00162	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.9e-05	0.00158	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.86e-05	0.00157	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.82e-05	0.00156	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.71e-05	0.00154	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	7.65e-05	0.00152	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.64e-05	0.00152	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.55e-05	0.00151	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.37e-05	0.00147	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.25e-05	0.00145	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.11e-05	0.00142	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.02e-05	0.0014	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.85e-05	0.00137	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.82e-05	0.00136	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.73e-05	0.00134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.69e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.58e-05	0.00131	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.47e-05	0.00129	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.46e-05	0.00129	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.45e-05	0.00129	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.3e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.3e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.13e-05	0.00122	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.02e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.98e-05	0.00119	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.87e-05	0.00117	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.79e-05	0.00116	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.77e-05	0.00115	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.76e-05	0.00115	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.69e-05	0.00113	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.68e-05	0.00113	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.61e-05	0.00112	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	5.53e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.53e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.52e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.46e-05	0.00109	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.24e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.23e-05	0.00104	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.23e-05	0.00104	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.16e-05	0.00103	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.14e-05	0.00102	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.05e-05	0.00101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.96e-05	0.000989	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.96e-05	0.000989	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.89e-05	0.000975	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.88e-05	0.000973	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.67e-05	0.000931	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.67e-05	0.000931	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.61e-05	0.000919	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.59e-05	0.000915	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.43e-05	0.000884	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.29e-05	0.000855	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.28e-05	0.000854	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.27e-05	0.000851	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.18e-05	0.000833	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.17e-05	0.000832	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.13e-05	0.000823	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.04e-05	0.000805	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.99e-05	0.000795	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.95e-05	0.000788	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.88e-05	0.000773	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.88e-05	0.000773	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.77e-05	0.000751	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.76e-05	0.000749	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.56e-05	0.00071	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.53e-05	0.000704	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.47e-05	0.000692	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.47e-05	0.000691	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.47e-05	0.000691	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.41e-05	0.000681	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.33e-05	0.000663	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.23e-05	0.000644	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.21e-05	0.00064	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.18e-05	0.000634	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.17e-05	0.000633	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.12e-05	0.000622	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.12e-05	0.000622	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.1e-05	0.000618	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.09e-05	0.000616	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.02e-05	0.000602	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.99e-05	0.000595	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.97e-05	0.000592	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.93e-05	0.000584	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.9e-05	0.000577	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.87e-05	0.000573	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.86e-05	0.00057	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.83e-05	0.000565	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.82e-05	0.000561	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.72e-05	0.000543	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.71e-05	0.00054	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.66e-05	0.000531	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000527	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.64e-05	0.000526	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.62e-05	0.000522	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.62e-05	0.000522	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.57e-05	0.000512	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.52e-05	0.000503	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.52e-05	0.000502	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.51e-05	0.0005	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.39e-05	0.000478	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.39e-05	0.000476	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.38e-05	0.000474	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.36e-05	0.000471	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000457	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.28e-05	0.000454	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.25e-05	0.000449	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.25e-05	0.000449	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.15e-05	0.000429	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.13e-05	0.000424	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.09e-05	0.000417	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.07e-05	0.000413	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.06e-05	0.000412	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.00041	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2e-05	0.000398	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.98e-05	0.000394	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.92e-05	0.000384	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.91e-05	0.000381	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000378	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000376	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.82e-05	0.000364	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.82e-05	0.000362	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.75e-05	0.000349	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.73e-05	0.000344	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.71e-05	0.000342	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.67e-05	0.000334	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.67e-05	0.000333	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.64e-05	0.000327	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.59e-05	0.000318	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.59e-05	0.000317	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-05	0.000315	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000311	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.55e-05	0.000309	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.51e-05	0.000302	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000289	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.42e-05	0.000284	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.41e-05	0.000282	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.00028	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.4e-05	0.000278	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.000277	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000274	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.36e-05	0.000271	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.35e-05	0.000268	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.28e-05	0.000255	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000253	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.25e-05	0.000249	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000247	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.22e-05	0.000244	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000236	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.17e-05	0.000234	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000233	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.15e-05	0.000229	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.07e-05	0.000214	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.05e-05	0.00021	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.03e-05	0.000206	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.03e-05	0.000205	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.73e-06	0.000194	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.6e-06	0.000191	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.4e-06	0.000187	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.35e-06	0.000187	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.95e-06	0.000178	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.94e-06	0.000178	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.68e-06	0.000173	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.48e-06	0.000169	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.95e-06	0.000158	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.76e-06	0.000115	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.51e-06	0.00011	CbGpPWpGaD
